Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
NYXH Nyxoah	$6.40 -0.8%	$7.39	$5.55 ▼ $11.87	$219.86M	1.61	167,175 shs	24,022 shs
SGHT Sight Sciences	$4.23 +0.5%	$3.87	$2.03 ▼ $7.03	$220.47M	2.44	129,864 shs	103,337 shs
SPAI Safe Pro Group	$6.11 -10.0%	$3.55	$1.47 ▼ $7.05	$109.78M	N/A	449,000 shs	580,405 shs
STIM Neuronetics	$3.38 +5.6%	$3.77	$0.52 ▼ $5.92	$211.60M	1.78	1.44 million shs	2.35 million shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
NYXH Nyxoah	+0.31%	-1.83%	-14.91%	-16.77%	-21.63%
SGHT Sight Sciences	-0.47%	+0.48%	+20.63%	+22.38%	-37.72%
SPAI Safe Pro Group	+19.33%	+67.24%	+78.68%	+149.63%	+678,999,900.00%
STIM Neuronetics	-5.88%	-9.60%	-28.73%	-19.40%	+231.61%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
NYXH Nyxoah	2.4612 of 5 stars	3.5	3.0	1.4	0.0	0.6
SGHT Sight Sciences	1.4327 of 5 stars	1.2	3.0	3.0	3.3	0.6
SPAI Safe Pro Group	0.9448 of 5 stars	2.0	0.0	3.1	1.7	0.0
STIM Neuronetics	1.4136 of 5 stars	3.5	1.0	0.6	0.8	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
NYXH Nyxoah	3.00	Buy	$15.00	134.38% Upside
SGHT Sight Sciences	2.43	Hold	$4.42	4.41% Upside
SPAI Safe Pro Group	4.00	Strong Buy	$8.00	30.93% Upside
STIM Neuronetics	3.00	Buy	$7.00	107.10% Upside

Current Analyst Ratings Breakdown

Latest SPAI, STIM, NYXH, and SGHT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2025	SGHT Sight Sciences	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$3.60 ➝ $4.50
8/8/2025	SGHT Sight Sciences	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$3.00 ➝ $5.00
8/6/2025	STIM Neuronetics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$8.00 ➝ $7.00
7/17/2025	SPAI Safe Pro Group	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$8.00
7/15/2025	SGHT Sight Sciences	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$3.00 ➝ $4.00
6/18/2025	SGHT Sight Sciences	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$3.50 ➝ $4.00

(Data available from 8/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
NYXH Nyxoah	$4.89M	44.58	N/A	N/A	$2.45 per share	2.61
SGHT Sight Sciences	$79.87M	2.77	N/A	N/A	$1.34 per share	3.16
SPAI Safe Pro Group	$2.17M	45.53	N/A	N/A	$0.16 per share	38.19
STIM Neuronetics	$74.89M	2.98	N/A	N/A	$0.48 per share	7.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
NYXH Nyxoah	-$64.10M	-$2.30	N/A	N/A	N/A	-1,541.84%	-79.18%	-54.92%	11/5/2025 (Estimated)
SGHT Sight Sciences	-$51.51M	-$0.96	N/A	N/A	N/A	-64.23%	-59.38%	-36.43%	11/6/2025 (Estimated)
SPAI Safe Pro Group	-$7.43M	-$0.80	N/A	∞	N/A	-731.46%	-328.85%	-248.09%	9/25/2025 (Estimated)
STIM Neuronetics	-$43.71M	-$1.13	N/A	N/A	N/A	-43.47%	-156.36%	-35.69%	11/11/2025 (Estimated)

Latest SPAI, STIM, NYXH, and SGHT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2025	Q2 2025	NYXH Nyxoah	-$0.62	-$0.63	-$0.01	-$0.63	$1.33 million	$1.58 million
8/14/2025	Q2 2025	SPAI Safe Pro Group	N/A	-$0.13	N/A	-$0.13	N/A	$0.09 million
8/7/2025	Q2 2025	SGHT Sight Sciences	-$0.25	-$0.23	+$0.02	-$0.23	$18.18 million	$19.56 million
8/5/2025	Q2 2025	STIM Neuronetics	-$0.08	-$0.15	-$0.07	-$0.15	$36.80 million	$38.11 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
NYXH Nyxoah	N/A	N/A	N/A	N/A	N/A
SGHT Sight Sciences	N/A	N/A	N/A	N/A	N/A
SPAI Safe Pro Group	N/A	N/A	N/A	N/A	N/A
STIM Neuronetics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
NYXH Nyxoah	0.29	2.63	2.38
SGHT Sight Sciences	0.57	10.01	9.49
SPAI Safe Pro Group	0.06	1.64	1.27
STIM Neuronetics	1.76	2.02	1.84

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
NYXH Nyxoah	N/A
SGHT Sight Sciences	55.51%
SPAI Safe Pro Group	N/A
STIM Neuronetics	53.59%

Insider Ownership

Company	Insider Ownership
NYXH Nyxoah	N/A
SGHT Sight Sciences	28.90%
SPAI Safe Pro Group	54.80%
STIM Neuronetics	9.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
NYXH Nyxoah	110	34.06 million	N/A	Not Optionable
SGHT Sight Sciences	210	52.37 million	37.23 million	Optionable
SPAI Safe Pro Group	11	16.17 million	7.31 million	N/A
STIM Neuronetics	180	66.12 million	59.65 million	Optionable

SPAI, STIM, NYXH, and SGHT Headlines

Recent News About These Companies

104,597 Shares in Neuronetics, Inc. (NASDAQ:STIM) Purchased by Informed Momentum Co LLC

August 15, 2025 | marketbeat.com

Citizens Financial Group Inc. RI Invests $305,000 in Neuronetics, Inc. (NASDAQ:STIM)

August 10, 2025 | marketbeat.com

Canaccord Genuity Group Has Lowered Expectations for Neuronetics (NASDAQ:STIM) Stock Price

August 7, 2025 | marketbeat.com

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 6, 2025 | globenewswire.com

Neuronetics, Inc. (NASDAQ:STIM) Q2 2025 Earnings Call Transcript

August 6, 2025 | msn.com

Neuronetics (NASDAQ:STIM) Announces Quarterly Earnings Results, Misses Expectations By $0.07 EPS

August 6, 2025 | marketbeat.com

Neuronetics, Inc. (STIM) Q2 2025 Earnings Call Transcript

August 5, 2025 | seekingalpha.com

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

August 5, 2025 | manilatimes.netM

What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings

August 5, 2025 | finance.yahoo.com

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

August 5, 2025 | zacks.com

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

August 4, 2025 | globenewswire.com

Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS

August 2, 2025 | msn.com

Neuronetics (STIM) Projected to Post Earnings on Tuesday

July 30, 2025 | marketbeat.com

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

July 30, 2025 | globenewswire.com

Kestra Private Wealth Services LLC Purchases Shares of 68,977 Neuronetics, Inc. (NASDAQ:STIM)

July 29, 2025 | marketbeat.com

Nkcfo LLC Takes Position in Neuronetics, Inc. (NASDAQ:STIM)

July 28, 2025 | marketbeat.com

Neuronetics taps local industry veteran as new CFO

July 15, 2025 | bizjournals.com

Neuronetics Names Pfanstiel as CFO to Succeed Furlong

July 15, 2025 | marketwatch.com

Neuronetics Appoints New Chief Financial Officer

July 15, 2025 | finance.yahoo.com

Neuronetics names Steven Pfanstiel chief financial officer

July 15, 2025 | massdevice.com

Neuronetics Appoints New Chief Financial Officer

July 15, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SPAI, STIM, NYXH, and SGHT Company Descriptions

Nyxoah NASDAQ:NYXH

$6.40 -0.05 (-0.78%)

Closing price 04:00 PM Eastern

Extended Trading

$6.40 0.00 (0.00%)

As of 06:16 PM Eastern

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Sight Sciences NASDAQ:SGHT

$4.23 +0.02 (+0.48%)

Closing price 04:00 PM Eastern

Extended Trading

$4.01 -0.22 (-5.18%)

As of 05:59 PM Eastern

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

Safe Pro Group NASDAQ:SPAI

$6.11 -0.68 (-10.01%)

Closing price 04:00 PM Eastern

Extended Trading

$6.13 +0.02 (+0.33%)

As of 07:57 PM Eastern

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.

Neuronetics NASDAQ:STIM

$3.38 +0.18 (+5.63%)

Closing price 04:00 PM Eastern

Extended Trading

$3.36 -0.02 (-0.74%)

As of 07:50 PM Eastern

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time